Fidabio Overview
- Year Founded
-
2012
- Status
-
Private
- Employees
-
29
- Latest Deal Type
-
Series B
- (Upcoming)
- Investors
-
3
Fidabio General Information
Description
Operator of a biophysics platform intended to ease the process of quantitative characterization and quantification of proteins and nanoparticles. The company's platform utilizes a new proprietary technology that allows early detection of immune responses, makes affinity assessment significantly faster than existing methods, and requires small sample volumes, enabling researchers and drug developers to study complex interactions and quantifications using simple workflows with direct measurement in purified and unpurified matrices, labeled and label-free.
Contact Information
Website
www.fidabio.comCorporate Office
- Generatorvej 6A
- 2860 Soborg
- Denmark
Corporate Office
- Generatorvej 6A
- 2860 Soborg
- Denmark
Fidabio Timeline
Fidabio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Later Stage VC (Series B) | Upcoming | Generating Revenue | ||||
| 8. Later Stage VC (Series A) | 16-Dec-2025 | Completed | Generating Revenue | |||
| 7. Later Stage VC | 24-Oct-2024 | Completed | Generating Revenue | |||
| 6. Later Stage VC | 16-May-2023 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series 1) | 30-May-2022 | Completed | Generating Revenue | |||
| 4. Later Stage VC | 31-Dec-2021 | Completed | Generating Revenue | |||
| 3. Later Stage VC | 31-Dec-2020 | Completed | Generating Revenue | |||
| 2. Grant | 01-Dec-2019 | $2.2M | $667K | Completed | Generating Revenue | |
| 1. Later Stage VC | 26-Jun-2019 | $667K | $667K | Completed | Generating Revenue |
Fidabio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Preference | ||||||||
| Preference | ||||||||
| Preference | ||||||||
| Preference | ||||||||
| Preference | ||||||||
| Preference | ||||||||
| Preference | 30,768 | $26.55 | $26.55 | 1x | $26.55 | 9.22% | ||
| Series 1 | 36,818 | $18.7 | $18.7 | 1x | $18.7 | 11.04% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Fidabio Comparisons
Industry
Financing
Details
Fidabio Competitors (4)
One of Fidabio’s 4 competitors is NanoTemper Technologies, a Corporation company based in Munich, Germany.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| NanoTemper Technologies | Corporation | Munich, Germany | ||||
| Refeyn | Venture Capital-Backed | Oxford, United Kingdom | ||||
| Fluidic Analytics | Venture Capital-Backed | Royston, United Kingdom | ||||
| Cytiva | Formerly Accelerator/Incubator backed | Marlborough, MA |
Fidabio Patents
Fidabio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025256713-A1 | A spectral related intensity change (sric) method, a binding related intensity change (bric) method for determining a characteristic parameter of particles and a folding related intensity change (fric) method | Pending | 11-Jun-2024 | ||
| WO-2025201612-A1 | A sensor system for fluorescence detection | Pending | 27-Mar-2024 | ||
| EP-4792117-A1 | A method of determining a binding parameter between a first particle and a second particle | Pending | 13-Oct-2023 | ||
| WO-2025077984-A1 | A method of determining a binding parameter between a first particle and a second particle | Inactive | 13-Oct-2023 | ||
| EP-4777814-A1 | A method of determining a parameter of a sample of a substance comprising particles in a liquid | Pending | 13-Sep-2023 | G01N15/0205 |
Fidabio Signals
Fidabio Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Fåhraeus Startup and Growth | Venture Capital | Minority | ||
| Horizon 2020 | Government | |||
| Denmark's Export and Investment Fund | Venture Capital | Minority |
Fidabio FAQs
-
When was Fidabio founded?
Fidabio was founded in 2012.
-
Where is Fidabio headquartered?
Fidabio is headquartered in Soborg, Denmark.
-
What is the size of Fidabio?
Fidabio has 29 total employees.
-
What industry is Fidabio in?
Fidabio’s primary industry is Discovery Tools (Healthcare).
-
Is Fidabio a private or public company?
Fidabio is a Private company.
-
What is Fidabio’s current revenue?
The current revenue for Fidabio is .
-
How much funding has Fidabio raised over time?
Fidabio has raised $16.4M.
-
Who are Fidabio’s investors?
Fåhraeus Startup and Growth, Horizon 2020, and Denmark's Export and Investment Fund have invested in Fidabio.
-
Who are Fidabio’s competitors?
NanoTemper Technologies, Refeyn, Fluidic Analytics, and Cytiva are competitors of Fidabio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process